摘要 |
The present invention relates to a method for predicting the concentration or the mass of haemoglobin or an approximation thereof, respectively, in a body fluid and/or an extracorporeal sample thereof of a patient at a later, second point of time, the patient having theoretically or in reality been administered a certain dose of an erythropoesis stimulating agent at an earlier, first point of time. It relates further to a method for determining the dose of an erythropoesis stimulating agent to be administered to a patient, to a method for determining whether a patient is affected by circumstances leading to the loss of haemoglobin, to corresponding devices and to an erythropoesis stimulating medicament for use in the treatment of anemia. Finally the present invention relates to corresponding means, digital storage means, a computer program product, and a computer program. |
申请人 |
FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH |
发明人 |
CHAMNEY, PAUL;MOISSL, ULRICH;WABEL, PETER;WIESKOTTEN, SEBASTIAN;NIER, VOLKER |